Our ChaESAR Technology:
For the Development of First-in-Class RNA Drugs
Chimeron Bio has developed a novel nanoparticle technology called “ChaESAR” – Chimera Encased Self Amplifying RNA – that harness the properties of self-amplifying RNA and synthetic genomics to engineer novel RNA drugs.
This unique particle lets us encase and protect the mRNA and deliver to various tissues.
We are advancing the field of saRNA biology by applying ChaeSAR technology to the development of treatment solutions beyond vaccines and across therapeutic areas.
Explore Our Pipeline of saRNA-Based Medicines
See how Chimeron Bio is applying ChaESAR to develop therapeutics in our key focus areas of oncology, liver, and kidney-related genetic disorders and infectious diseases.